Subscribe to Newsletter

Jan van de Winkel

President and CEO at Genmab

Van de Winkel has over 30 years of experience in the therapeutic antibody field. Under van de Winkel’s leadership, Genmab has achieved many key milestones including the approval of five  medicines for treatment of cancer and other diseases, and 20 industry partnerships.

If you weren’t in the pharma industry, what would you be doing?

If I wasn’t in the biotech industry, I would return to the place it all began for me – immunology research. These formative years in the research field inspired me and gave me a sense of belonging and purpose, the same foundation on which I built Genmab as a leading biotech innovation powerhouse. 

At Genmab, we are driven by purpose and curiosity. Our purpose drives us to transform the lives of people with cancer, and our curiosity has led to the scientific breakthroughs that have allowed us to pursue our mission.   

Throughout my 35 years in the immunology field, I have had a sense of inquisitiveness and desire for lifelong learning that I don’t think will ever go away. I’m a naturally curious person, which has led me where I am today. And there is nowhere else I’d rather be – connected to science and always working towards making a real difference to the lives of patients.  

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine